par 166 (Benztropine 2 mg)
Pill imprint par 166 has been identified as Benztropine mesylate 2 mg.
Benztropine is used in the treatment of extrapyramidal reaction; parkinson's disease; hyperhidrosis and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for par 166 (Benztropine 2 mg)
- 2 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- N - Not a controlled drug
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|00182-1701||Goldline Laboratories Inc|
|63739-0035||McKesson Packaging Services|
|68115-0044||Dispensexpress Inc (repackager)|
|66336-0699||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about benztropine
- Benztropine tablets
- Benztropine (Advanced Reading)
- Benztropine Injection (Advanced Reading)
- Other brands: Cogentin